Chronic Migraine Treatment Market Analysis By Treatment type (medications (abortive and preventive), nerve blocks, and neuromodulation devices), By Distribution channel (hospitals, retail pharmacies, and online pharmacies), By Geography (North America, Europe, Asia-Pacific, and the rest of the world), By End-users (hospitals, clinics, and home care settings), By Mode of administration (oral, injectable, and transdermal), By Age group (adults and pediatrics), By Gender (women compared to men) & Forecast 2024-2035
- PUBLISHED ON
- 4/14/2023
- NO OF PAGES
- 281
- CATEGORY
- Healthcare & Life Sciences
The chronic migraine treatment market is a rapidly growing segment of the pharmaceutical industry. Chronic migraines are a type of headache disorder that is characterized by recurring headaches that last for more than 15 days per month. The condition is often accompanied by other symptoms, such as nausea, vomiting, and sensitivity to light and sound.
The global chronic migraine treatment market is expected to continue to grow in the coming years due to factors such as the increasing prevalence of chronic migraines and the growing demand for more effective treatments. Additionally, the development of new and innovative treatments is expected to further drive the growth of the market.
Currently, the market for chronic migraine treatments is dominated by a few key players, including Allergan, Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., and Amgen, Inc. These companies offer a range of treatments, including oral medications, injectables, and neuromodulation devices.
One of the key drivers of the market is the growing demand for more effective treatments for chronic migraines. Currently available treatments, such as triptans and nonsteroidal anti-inflammatory drugs (NSAIDs), are often ineffective for chronic migraine sufferers. The development of new treatments, such as monoclonal antibodies that target calcitonin gene-related peptide (CGRP), has shown promising results in clinical trials and is expected to be a major driver of growth in the coming years.
Overall, the chronic migraine treatment market is expected to continue to grow as the demand for more effective treatments for this debilitating condition increases.
Segment Overview
The chronic migraine treatment market can be segmented based on various factors, including:
1. Treatment type: The chronic migraine treatment market can be segmented based on the type of treatment, such as medications (abortive and preventive), nerve blocks, and neuromodulation devices.
2. Distribution channel: The market can also be segmented based on the distribution channel, such as hospitals, retail pharmacies, and online pharmacies.
3. Geography: The chronic migraine treatment market can be segmented based on geography, such as North America, Europe, Asia-Pacific, and the rest of the world.
4. End-users: The market can be segmented based on end-users, such as hospitals, clinics, and home care settings.
5. Mode of administration: The market can be segmented based on the mode of administration, such as oral, injectable, and transdermal.
6. Age group: The market can be segmented based on age group, such as adults and pediatrics.
7. Gender: The market can also be segmented based on gender, as the prevalence of chronic migraine is higher in women compared to men.
These segments can help pharmaceutical companies, healthcare providers, and policymakers to better understand the market dynamics and develop strategies accordingly.
Geographical Overview
The market for chronic migraine treatment is a global one, with demand for these treatments present in almost every country in the world. The top markets for chronic migraine treatment include North America, Europe, Asia-Pacific, and the Middle East and Africa.
North America is the largest market for chronic migraine treatment, driven by the high incidence of migraine and the increasing awareness and diagnosis of chronic migraine in the region. The United States is the largest market in this region, accounting for a significant portion of the global market share.
Europe is the second-largest market for chronic migraine treatment, with a significant portion of demand coming from countries such as Germany, France, and the United Kingdom. The high prevalence of migraine in this region and the increasing focus on innovative and advanced treatments are driving demand for these treatments.
The Asia-Pacific region is expected to see significant growth in the coming years, driven by the rising incidence of migraine in countries such as China and India. The increasing awareness and diagnosis of chronic migraine in this region, along with the growing healthcare infrastructure and rising healthcare spending, are also contributing to the growth of the market in this region.
The Middle East and Africa are also expected to see growth in the market for chronic migraine treatment, driven by the increasing incidence of migraine and the growing demand for advanced treatments in these regions.
Overall, the global market for chronic migraine treatment is expected to continue to grow in the coming years, driven by the increasing prevalence of chronic migraine, the growing aging population, and the increasing demand for innovative and advanced treatments.
COVID Impact
The COVID-19 pandemic has had a significant impact on the chronic migraine treatment market. The pandemic has led to a decrease in the number of patient visits to healthcare facilities, including those for migraine treatment. Additionally, the pandemic has also led to disruptions in the supply chain of many drugs, including migraine medications, which has further impacted the market.
As a result of the pandemic, many healthcare providers have had to shift to telemedicine and remote consultations for migraine treatment, which has impacted the way medication is prescribed and delivered. This shift has also led to delays in diagnosis and treatment for some patients, as well as changes in treatment plans for others.
Furthermore, the pandemic has led to an increase in stress and anxiety levels, which can trigger or exacerbate migraines. This has led to an increase in demand for migraine medication among individuals who may not have previously sought treatment for migraines.
On the other hand, the pandemic has also spurred innovation and development in the chronic migraine treatment market. For instance, there has been a renewed focus on non-invasive and digital treatments, such as neuromodulation devices and telemedicine services, which may be more accessible and convenient for patients during the pandemic.
In summary, while the COVID-19 pandemic has led to a decrease in patient visits to healthcare facilities and disruptions in the supply chain of migraine medication, it has also spurred innovation and development in the chronic migraine treatment market. The long-term impact of the pandemic on the chronic migraine treatment market remains to be seen, and will likely depend on the course of the pandemic and the effectiveness of measures taken to mitigate its impact.
Competitive Analysis
The chronic migraine treatment market is highly competitive, with several established and emerging players offering a variety of drugs and therapies.
1. Allergan plc
2. Teva Pharmaceutical Industries Ltd.
3. Eli Lilly and Company
4. Pfizer Inc.
5. GlaxoSmithKline plc
6. AstraZeneca plc
7. AbbVie Inc.
8. Johnson & Johnson Services Inc.
9. Endo Pharmaceuticals Inc.
10. Eisai Co. Ltd.
Allergan plc is the market leader in the chronic migraine treatment market, with its Botox product being the only FDA-approved drug for chronic migraine prophylaxis. Other players such as Teva Pharmaceutical Industries Ltd. and Eli Lilly and Company also have their own drugs approved for chronic migraine prophylaxis. Pfizer Inc. and GlaxoSmithKline plc also have significant market share in this segment, offering several migraine medications such as Imitrex and Maxalt.
The market is also witnessing the emergence of new players offering innovative therapies and drugs for chronic migraine treatment. For instance, eNeura Therapeutics offers the first non-invasive, drug-free migraine treatment device, which uses magnetic stimulation to alleviate symptoms.
In addition to pharmaceutical companies, there are also medical device companies such as Cefaly Technology, offering a wearable device that provides external neurostimulation to alleviate migraine pain. Other emerging players in the market include Biohaven Pharmaceuticals and Alder Biopharmaceuticals, both of which are developing new drugs for migraine prevention and treatment.
Overall, the chronic migraine treatment market is expected to continue to grow, driven by increasing prevalence of migraine worldwide and a growing demand for effective treatment options.
Historic Year: 2016-2022
Forecast: 2024-2035
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Select a license type that suits your business needs
US $4250
Only Four Thousand Two Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $5250
Only Five Thousand Two Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $6250
Only Six Thousand Two Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI